Loading...

Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors

CTLA-4, PD-1, and PD-L1 monoclonal antibodies, commonly known as immune checkpoint inhibitors, are used for the treatment of various malignancies. The mechanism of action involves the inhibition of negative regulators of immune activation, which results in many patients developing immune-related adv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Dermatol
Main Authors: Zarbo, A., Belum, V.R., Sibaud, V., Oudard, S., Postow, M.A., Hsieh, J.J., Motzer, R.J., Busam, K.J., Lacouture, M.E.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459625/
https://ncbi.nlm.nih.gov/pubmed/27943234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15237
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!